Validation of the Kansas City Cardiomyopathy Questionnaire in Symptomatic Obstructive Hypertrophic Cardiomyopathy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Validation of the Kansas City Cardiomyopathy Questionnaire in Symptomatic Obstructive Hypertrophic Cardiomyopathy

Published:2022-08 Issue:8 Volume:10 Page:531-539
ISSN:2213-1779
Container-title:JACC: Heart Failure
language:en
Short-container-title:JACC: Heart Failure

Author:

Nassif Michael,Fine Jennifer T.,Dolan Chantal,Reaney Matthew,Addepalli Prithvi,Allen Veleka D.,Sehnert Amy J.,Gosch Kensey,Spertus John A.

Funder

MyoKardia

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference23 articles.

1. Clinical course and management of hypertrophic cardiomyopathy;Maron;N Engl J Med,2018

2. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC);Elliott;Eur Heart J,2014

3. Treatment for Heart Failure: Endpoints for Drug Development Guidance for Industry,2019

4. Study design and rationale of EXPLORER-HCM: evaluation of mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy;Ho;Circ Heart Fail,2020

5. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure;Green;J Am Coll Cardiol,2000

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mavacamten in Obstructive Hypertrophic Cardiomyopathy Patients Referred for Septal Reduction;Journal of the American College of Cardiology;2024-09

2. Patient Reported Outcome Measures in Adults with Fontan Circulatory Failure;Journal of Clinical Medicine;2024-07-17

3. REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic LMNA -Related Dilated Cardiomyopathy;Circulation: Heart Failure;2024-07

4. Social Determinants of Health, Adherence, and Outcomes in Heart Failure: The Role of Social Prescribing;Canadian Journal of Cardiology;2024-06

5. Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy;New England Journal of Medicine;2024-05-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3